InsiderTrades.com logo
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

SPE Insider Trading

Insider Ownership Percentage: 48.88%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Sopheon Insider Trading History Chart

This chart shows the insider buying and selling history at Sopheon by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sopheon Share Price & Price History

Current Price: GBX 990
Price Change: +0.30 (1.20%)
As of 02/21/2024 12:59 AM ET

This chart shows the closing price history over time for SPE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Mysterious Gold Leverage Just Announced
From Stansberry Research   |   Ad
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Find out what it is and see how you can get in with just a few dollars.

Sopheon Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2023Gregory CoticchiaInsiderBuy3,500GBX 676£23,660
8/31/2021Stuart A SilcockInsiderSell7,450GBX 963£71,743.50
See Full Table
Mysterious Gold Leverage Just Announced
From Stansberry Research   |   Ad
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Find out what it is and see how you can get in with just a few dollars.

SEC Filings (Institutional Ownership Changes) for Sopheon (LON:SPE)

41.39% of Sopheon stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sopheon logo
Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. Its software solutions include Accolade, an enterprise management solution that identify, evaluate, and execute against the right strategic priorities for its portfolio; Acclaim Ideas, an idea management solution; Acclaim Products, which allows product people to track product health, prioritize trade-offs, inform stakeholders, and make decisions; and Acclaim Projects, a project management solution. The company was formerly known as PolyDoc and changed its name to Sopheon plc in 1999. Sopheon plc was founded in 1993 and is based in West End, the United Kingdom.
Read More on Sopheon

Today's Range

Now: GBX 990
Low: 990
High: 990

50 Day Range

MA: GBX 989.30
Low: 985
High: 990

52 Week Range

Now: GBX 990
Low: 470
High: 1,000

Volume

1,136 shs

Average Volume

36,595 shs

Market Capitalization

£106.03 million

P/E Ratio

N/A

Dividend Yield

0.33%

Beta

0.44

Who are the company insiders with the largest holdings of Sopheon?

Sopheon's top insider investors include:
  1. Gregory Coticchia (Insider)
Learn More about top insider investors at Sopheon.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>